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THE purpose of this study was to investigate the effects
of Tityus serrulatus venom (TSV) on murine perito-
neal  macrophages  evaluated  in  terms  of  activation.
The effects of crude TSV were analysed by detection of
cytokines,  oxygen  intermediate  metabolites  (H2O2)
and nitric oxide (NO) in supernatants of peritoneal
macrophages.  Several  functional  bioassays  were
employed including an in vitro model for envenomat-
ing: cytotoxicity of TSV was assessed using the lyses
percentage. Tumor necrosis factor (TNF) activity was
assayed by measuring its cytotoxic activity on L-929
cells, and interleukin-6 (IL-6) and interferon-g (IFN-g )
were  assayed  by  enzyme-linked  immunosorbent
assay,  whereas  NO  levels  were  detected  by  Griess
colorimetric reactions in culture supernatant of mac-
rophages  incubated  with  TSV  and  subsequently
exposed to either lipopolysaccharide or IFN-g . Incu-
bation  of  macrophages  with  TSV  increased  produc-
tion of IL-6 and IFN-g in a dose-dependent manner.
TNF  production  was  not  detected  in  supernatants
treated with TSV at any concentration. The increase in
IL-6 secretion was not associated with concentration-
dependent cytoxicity of TSV on these cells. These data
suggest that the cytotoxicity does not appear to be the
main cause of an increased cytokine production by
these  cells.  Although  NO  is  an  important  effector
molecule  in  macrophage  microbicidal  activity,  the
inducing  potential  of  the  test  compounds  for  its
release was found to be very moderate, ranging from
125 to 800 mM. Interestingly, NO levels of peritoneal
macrophages were  increased after  IFN-g . Moreover,
NO  production  had  an  apparent  effect  on  macro-
phage activity. The results obtained here also shown
that the TSV induces an important elevation in H2O2
release. These results combined with NO production
suggest that TSV possesses significant immunomodu-
latory activities capable of stimulating immune func-
tions in vitro.
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Introduction
Scorpion venoms, in terms of their biological proper-
ties,  chemical  composition,  toxicity,  biological
actions, and pharmacokinetic and pharmacodynamic
characteristics, vary enormously.
Tityus  serrulatus is  considered one  of  the  most
dangerous  species  for  humans  in  Brazil,  and  is
responsible for many clinical cases of envenomation
in the southern region of this country. This venom is
capable of exerting a variety of effects on excitable
tissues, due to their action in the peripheral nervous
system enhancing the release of neurotransmitters.1
Victims of envenoming by a scorpion suffer a variety
of pathologies, involving mainly sympathetic (tachy-
cardia,  hypertension,  sweating  and  mydriasis)  and
parasympathetic  (bradycardia,  hypotension,  secre-
tions  and  miosis)  stimulation  as  well  as  central
manifestations such as irritability, hyperthermia, vom-
iting, tremor and convulsion. To address these issues,
basic information obtained from representative exper-
imental animal models using adequate venom samples
as  inflammatory  inducers  are  necessary.  Previous
studies have shown different susceptibility to venom
varies according to the strain of mice used.2,3It is well
established  that  the  predominant  lethal  action  of
scorpion  venoms  exerts  a  variety  of  effects  on
excitable tissues. For snake venoms, it is well known
that lethality and toxicity possess an enormous variety
according  to  the  age,  sex,  nutritional  state  and
geographic regions where the animal were captured.4
To minimise the experimental bias, BALB/c mice and
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were used throughout all experiments.
Macrophages have been shown to be involved in
different  homeostatic mechanisms  and  pathological
events, and may be engaged in complex interactions.
Macrophages are  involved  in  several  areas of  body
function,  such  as  phagocytosis,  enzyme  liberation,
free radical generation, and as mediators of inflamma-
tory processes. Cytokines release by macrophages has
shown that excessive or insufficient production may
significantly  contribute to the pathophysiology of a
range  of  diseases.5–8 Generally,  the  treatment  of
macrophages with lead results in disregulation of the
production of inflammatory cytokines, tumor necro-
sis  factor  (TNF),  interleukin  (IL)-1  and  IL-6,  and
preferential production of the TH1 type of cytokines
interferon-g (IFN-g) and IL-2.
In this study, the effect of TSV on cytokines and
nitric oxide (NO) production and macrophage activa-
tion  were  studied.  Immunomodulatory  effects
induced  by  this  venom  for  NO  production  and
macrophage  activation  were  compared  with  those
obtained in the cells stimulated with lipopolysacchar-
ide (LPS) or IFN-g.
Materials and methods
Chemicals, reagents and buffers 
Actinomycin  D,  orthophenyldiamine  (OPD)  and
sodium nitrate (NO) were purchased from Sigma (St
Louis,  MO,  USA),  fetal  calf  serum  (FCS)  and  RPMI-
1640 medium were purchased from Cutilab (Campi-
nas,  SP,  Brazil),  murine  anti-IL-6  (clones  MP5–20F3
and  MP5–32.C.11),  recombinant  IL-6,  anti-IFN-g
(clones XGM1.2  and AN18) and recombinant IFN-g
were  purchased  from  Pharmingen  (Torreyana,  San
Diego,  CA,  USA),  and  recombinant TNF  was  pur-
chased  from  Boehringer  Mannheim  (Mannheim,
Germany).
Scorpion venom
T. serrulatus scorpions were provided by Laborat´ orio
de  Artr´ opodos,  Instituto  Butantan  (SP,  Brazil).  The
venom  was  obtained  by  electrostimulation  by  the
method  previously  described.9 In  brief,  15–20V
electrical  stimuli  were  repeatedly  applied  to  the
scorpion  and  the  venoms  were  collected  with  a
micropipette, lyophilised  and stored at –20°C. Ven-
oms are pools from more than 40 adult specimens and
referred to as TSV.
Animals
BALB/c female mice (18–20g), obtained from Insti-
tuto Butantan, were used throughout the study. Mice
were  maintained  and  used  according  to  animal
welfare International reccomendations.10
Stimulation of mouse peritoneal macrophages
Groups of mice from BALB/c were sacrificed and their
cells were harvested by peritoneal lavage.11The cells
were seeded in 96-well microtiter plates at a concen-
tration of 1 ´ 106 cells/ml and cultured in RPMI-1640
medium supplemented with 10% FCS. After incuba-
tion at 37°C for 2h in humidified 5% CO2, the plates
were then washed twice with RPMI-1640 medium to
remove  non-adherent  cells  and  the  adherent  cells
were referred as macrophages. More than 95% of the
cells were identified as macrophages by morphology
as well as by their ability to ingest IgG-opsonised red
cells.12These cells were exposed to different concen-
trations  of TSV  in  RPMI-1640  containing  10%  FCS.
After incubation at 37°C for various intervals of time
in  a humidified  atmosphere of 5% CO2,  the  super-
natants  were  collected  and  stored  at  –20°C  until
assayed  for  the  presence  of  H2O2,  NO  and
cytokines.
H2O2 determination
Peritoneal macrophages  obtained as  already  descri-
bed,  where  1  ´ 106 cells/ml  were  seeded  and
incubated  in  a  volume  of  100ml  with  no  stimuli
(control), or were stimulated with recombinant IFN-g
(10ng/ml) or TSV (different amounts (mg/ml)). After
incubation at 37°C for various intervals of time in a
humidified atmosphere of 5% CO2, the supernatants
were then collected for NO determination and 100ml
of  red  phenol  solution  containing  140 mM  NaCl,
10 mM K2PO4, 5.5 mM dextrose, and 5.5 mM horse-
radish peroxidase was added to the adherent cells for
H2O2 determination. After incubation  during  1h at
room temperature, 10ml  of 1M NaOH were added
and the absorbances were measured at 620nm, using
an automatic enzyme immunoassay reader.13
NO determination
The levels of NO in supernatants from macrophages
control or stimulated with TSV or IFN-g or TSV + IFN-g
were  assayed by  adding  100ml  of  freshly  prepared
Griess reagent14 to 100ml of the sample in 96-well
plates,  and then reading the absorbance at 540nm
10min  later  by  comparison  with  the  absorbance
curves of serial dilutions  of sodium nitrate in  com-
plete  culture  medium. The  minimum  level  of  NO
detectable under the assay conditions was 1nmol.
Cytokine determination
The levels of cytokines IL-6 and IFN-g in the culture
supernatants  were  assayed  by  a  two-site  sandwich
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Briefly,  ELISA  plates  were  coated  with  100ml
(1mg/ml)  of  the  monoclonal antibodies anti-IL-6 or
anti-IFN-g in 0.1M sodium carbonate buffer (pH 8.2)
and incubated for 6h at room temperature. The wells
were  then  washed  with  0.1%  phosphate-buffered
saline  (PBS/Tween-20)  and  blocked  with  100ml  of
10% FCS in  PBS for 2h at room temperature. After
washing, duplicate supernatant macrophage culture
samples of 50ml were added to each well. After 18h
of  incubation  at  4°C,  the  wells  were  washed  and
incubated with 100ml (2mg/ml) of the biotinylated
monoclonal antibodies anti-IL-6 or anti-IFN-g as sec-
ond antibodies for 45min at room temperature. After
a  final  wash,  the  reaction  was  developed  by  the
addition of OPD to each well. Optical densities were
measured  at  405nm  in  a  microplate  reader.  The
cytokine  content  of  each  sample  was  read  from  a
standard  curve  established  with  the  appropriate
recombinant cytokine (expressed in nanograms per
milliliter).  The  minimum  levels  of  each  cytokine
detectable in the conditions of the assays were 0.78
and 2.9ng/ml for IL-6 and IFN-g, respectively.
To measure the cytotoxicity of TNF present in the
supernatants from the macrophages, a standard assay
with L-929 cells, a fibroblast continuous cell line, was
used as described previously.16
Cytotoxicity determination
In brief, macrophage cells maintained in RPMI-1640
medium supplemented with 10% FCS were seeded at
1 ´ 105 cells/well on to a 96-well plate, and control
cells or treated cells were incubated at 37°C in a 5%
CO2 atmosphere. After different times of incubation,
the  supernatants were  removed and  the  remaining
live cells assessed by fixing and staining with crystal
violet (0.2% in 20% methanol). Absorbance (A) was
measured  in  each  well  by  reading  at  620nm  in  a
microplate  reader. The percentage cytotoxicity was
calculated  as  follows:  (Acontrol –  Asample/Acontrol)  ´
100. To determine the viability, in a separate group of
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FIG. 1. Effect of TSV on macrophage cytotoxicity and viability. Groups of BALB/c mice were sacrificed and their peritoneal
macrophages collected and stimulated in vitro with different amounts of TSV. (A) After different times of incubation of the
cultured peritoneal macrophages, the cytotoxicity percentages were determined. (B) For the kinetics of the effect of TSV on
cytotoxicity, the macrophages were obtained from mice and in vitro stimulated with 0.2mg/ml of TSV. Each point represents
the mean ± standard deviation value of samples from five experiments in different groups of five mice.macrophages  stimulated  with TSV,  8% Trypan  blue
solution  was  added  to  the  wells.  The  percentage
of  the  stained  cells  was  determined  in  a
hemacytometer.
Statistical analyses
Data are expressed as the mean ± standard deviation.
Statistical analyses were performed by Student’s t-test
and the level of significant was set at p < 0.05.
Results
Effect of TSV on macrophage viability
Different amounts of TSV were added to peritoneal
macrophage cultures. Stimulated and control cultures
were incubated in the same conditions and, after 24h,
a dose-dependent change occurred in macrophages
stimulated  with  TSV:  macrophages  treated  with
0.2–0.4mg/ml of TSV caused around 0.4% of the lyses
in cells (Figure 1A); 0.8–1.4mg/ml of TSV caused lyses
of around 0.1 and 0.2%, respectively (Fig. 1A). Finally,
concentrations  of  2.8–55mg/ml  of  TSV  had  little
effect on cells, causing effect cytotoxic around 0.05%
of macrophages lysed (Fig. 1A). The influence of the
TSV on the viability of the treated macrophages was
examined  by  trypan  blue  exclusion  in  a  separate
experiment in which the cells were incubated with
different  amounts  of  venom.  TSV  even  at  high
concentrations did not induce staining of the macro-
phages by the dye, indicating that the cells remained
viable (data not shown). To determine the kinetics of
the effects of TSV on cytotoxicity, the macrophages
were  obtained  from  mice  and  stimulated  with
0.2mg/ml of TSV (Fig. 1B). The highest cytotoxicity
percentage was observed 24h post-treatment.
Effect of TSV on in vitro cytokine and NO
production
To determine cytokine  production,  groups  of  mice
were sacrificed and their macrophages, which were
collected  by  peritoneal  lavage,  were  stimulated  in
vitro with different amounts of TSV (Fig. 2). The in
vitro stimulation of macrophages with TSV resulted in
the production of IL-6 in a dose-dependent manner.
The  maximum  production  of  IL-6  was  detected in
V.L. Retricevich
26 Mediators of Inflammation · Vol 11 · 2002
FIG.  2.  Cytokine  released  by  peritoneal  macrophages  from  BALB/c  mice.  Peritoneal  macrophages  were  obtained  and
stimulated in vitro as described in Fig. 1. IL-6 and IFN-g were assayed by ELISA assay using monoclonal antibodies as the
probe. Each point represents the mean ± standard deviation value of samples from five experiments in different groups of five
mice.cultures stimulated for 24h (Fig. 2). The levels of IL-6
in  groups  of  macrophages stimulated in vitro with
TSV  were  higher  when  compared  with  those
obtained  in  non-stimulated  cultures  (p >  0.001).
Figure  2  shows  that  the  levels  of  IFN-g started  to
appear after 24h in all cultures. The levels of IFN-g
increased in a dose-dependent manner until 72h in all
macrophage groups treated in vitro with TSV (Fig. 2).
The  levels  of  IFN-g in  groups  of  macrophages
stimulated in vitro with TSV were significantly higher
when  compared  with  those  obtained  in  control
cultures (p > 0.001). TNF levels were not detected in
these supernatants (data not shown).
The  levels  of  NO  increased  until  72h  in  all
macrophage  groups  stimulated  in  vitro with  TSV,
decreasing thereafter  (Fig.  3). The  levels  of  NO  in
groups  of  macrophages  stimulated  with TSV  were
significantly  higher  when  compared  with  those
obtained in non-stimulated cultures (p > 0.001).
Effect of TSV on in vitro activation
To compare macrophage activation, mice were sacri-
ficed and their macrophage collected by peritoneal
lavage and stimulated with different amounts of TSV.
The  effects  of  venom  on  macrophage  were  deter-
mined  by  measuring  oxygen  intermediate  metabo-
lites.  TSV  was  capable  of  increasing  macrophage
activation. As shown in Fig.  4,  in groups  of  macro-
phages treated with 0.2–1.4mg/ml of TSV, the highest
levels  of  activation  were  observed  48h  post-treat-
ment.  Similar  levels  of  activation  for  all  groups  of
macrophages stimulated with 2.8–11.3mg/ml of TSV
were observed 72h after this treatment. The lowest
levels  of  activation  were  observed  in  groups  of
macrophages treated with 22.5–55mg/ml.
In vitro inflammatory cytokines, H2O2 and NO
production on TSV stimulation
To compare the effects of TSV on the cytokines, H2O2
and NO production with LPS stimulation, groups of
mice  were  sacrificed  and  their  macrophages  were
collected by peritoneal lavage. TSV (55mg/ml) or LPS
(5mg/ml) were added to macrophage cultures and IL-
6,  IFN-g,  H2O2 and  NO  were  measured  in  these
supernatants after various times. As shown in Fig. 5,
similar  levels  of  IL-6 for all  groups of macrophages
stimulated with TSV or LPS were observed after 24h
using both treatments. For all groups of macrophages
treated with TSV or LPS, IL-6 levels decreased with an
increase in the time of stimulation. The levels of IFN-g
started to appear after 24h in both groups, increasing
Effect of TSV on murine macrophages
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FIG. 3. NO production. Peritoneal macrophages were obtained and stimulated in vitro as described in Fig. 1. NO levels were
detected by the Griess colorimetric reaction. Each point represents the mean ± standard deviation value of samples from five
experiments in different groups of five mice.
FIG. 4. Macrophage activation. Peritoneal macrophages were
obtained and stimulated in vitro as described in Fig. 1. The
activation  of  the  cultured  peritoneal  macrophages  was
determined by measuring the oxygen intermediate metabo-
lites  (H2O2).  Each  point  represents  the  mean  ±  standard
deviation value of samples from five experiments in different
groups of five mice.until 72h and decreasing thereafter (Fig. 5). Figure 6
shows the levels of H2O2 in macrophages stimulated
with TSV or LPS in vitro for 72h. The lowest levels of
H2O2 (p < 0.05%) were observed in cultures stimu-
lated with  LPS.  Figure  6  shows that  in  the  macro-
phages cultured with 0.4–55mg/ml of TSV the levels
of NO were lower than the macrophages stimulated
with LPS.
Effect of exogenous cytokine on macrophages
stimulated with TSV
To verify whether exogenous cytokine, such as IFN-g,
showed an effect on macrophages treated with TSV,
the  levels  of  H2O2 and  NO  were  determined. As
shown  in  Figure  7,  both  groups  of  macrophages
treated with TSV + IFN-g showed a marked increase in
H2O2 release  and  NO  production  when  compared
with  those  obtained  in  control  cultures. The  max-
imum H2O2 release and NO levels were detected in
cultures stimulated for 72h.
Discussion
T.  serrulatus is  an  aggressive  scorpion  found  in
Southeast  Brazil,  where  it  is  responsible  for  most
scorpion accidents in humans. A better understanding
of  the  host  response  may  contribute  to  improved
treatment strategies of the envenomating. To establish
the  optimal  conditions  ruling  macrophage–venom
interactions,  the  effect  of TSV  on  cytotoxicity  and
viability percentage were studied. This study shown
that  TSV  (0.2–55mg/ml)  did  not  induce  lyses  in
peritoneal macrophages from BALB/c mice.
With respect to immune response, recent studies
regarding the roles that cytokines may play in host
defenses also indicate the importance of this aspect of
the  host  response  to  envenomating. The  ability  of
TH1-type and TH2-type cytokines to bias the develop-
ment of immune responses to stimulus is known.17,18
A number of stimuli such as microbial infection, tissue
injury,  and  tumor  cells  can  active  macrophages  or
mononuclear phagocytes. These immune  cells  have
complex and multifactorial regulatory activities exer-
ted  through  the  production  of  various  cytokines,
reactive oxygen metabolites and NO.
Previous studies have shown that cytokines such as
TNF19 and IL-120 are key intermediates of  an  over-
responsive host–response reaction. TNF exerts a wide
spectrum of  biological activities and contributes to
the  pathophysiology  of  septic  shock. At  conditions
used in the present study, TNF release from murine
peritoneal macrophages was not observed after treat-
ment with TSV.
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FIG. 5. Comparision of cytokine released after TSV or LPS stimulation. Groups of mice were sacrificed and their peritoneal
macrophages were collected. Peritoneal macrophages were stimulated in vitro with 55mg/ml of TSV or 5mg/ml of LPS and,
after different time intervals, the supernatants were collected. IL-6 and IFN-g were assayed as described in Fig. 2. Each point
represents the mean value of samples from five experiments ± standard deviation in different groups of five mice.Effect of TSV on murine macrophages
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FIG. 6. H2O2 and NO production. Peritoneal macrophages were obtained and stimulated in vitro as described in Fig. 1. H2O2
levels and NO levels were determined 72h post-stimulation. Each point represents the mean ± standard deviation value of
samples from five experiments in different groups of five mice.
FIG. 7. H2O2 and NO release by peritoneal macrophages. Peritoneal macrophages were stimulated by 55mg/ml of TSV or IFN-g
(10ng/ml) or TSV + IFN-g. H2O2 and NO were determined as described in Fig. 6. Each point represents the mean ± standard
deviation value of samples from five experiments in different groups of five mice.Other studies carried out in inflammatory models
have indicated that pro-inflammatory substances and
some cytokines are deeply involved in the activation
of endothelial cells and leukocytes, leading them to
express on their cell  surface adhesion molecules.21
The results obtained in this study showed that TSV
enhances IL-6 release from murine peritoneal macro-
phages. These results agree with previous studies that
showed  IL-6  release  from  sera  mice  injected  with
venom,22 victims envenomated by a snake bite,23 and
murine peritoneal macrophage stimulated with snake
venom.24
IFN-g also  plays  an  important  role  in  the  lethal
response  to  stimuli  such  as  LPS,  particularly  in
mediating the lethal Shwartzman reaction.25 On the
contrary,  IFN-g is  a  key  cytokine  in  host  defenses
against  intracellular  organisms26 and  enhances  the
ability of peritoneal macrophages and Kupffer cells to
phagocytosis and to kill virulent Escherichia coli.27
Thus,  IFN-g may  exert  and  participate in  both  the
beneficial and detrimental effects of LPS. The present
study shows that TSV is capable of stimulating murine
peritoneal macrophages to release IFN-g. Cytokines
are  powerful  modulators  of  murine  macrophage
reactive oxygen intermediates such as H2O2, and O2
–,
and reactive nitrogen intermediates such as NO and
NO2
–.
The present study describes an experimental model
designed to test the hypothesis that TSV could exert
action  in  macrophage  activation. To  examine  this
possibility, different amounts of TSV were added to
cultured  macrophages,  and  the  activation  of  these
cells was determined. All amounts of TSV used for this
study  were  capable  of  activating  macrophages  to
release H2O2.
Reactive nitrogen intermediate production by mur-
ine macrophages is an important effector mechanism
against a variety of pathogens.28 In macrophages, NO
and other reactive nitrogen intermediates are derived
from L-arginine via an enzymatic pathway controlled
by  an  inducible  NO  synthase  (iNOS),29 and  their
synthesis are modulated by cytokines. While TNF and
IFN-g are  potent  activators of  iNOS,  IL-4  and  IL-10
suppress  it.30–32 NO  is  known  to  be  involved  in
multiple  biologically  important  reactions,  including
those  with  transition  metal  ions,  thiols,  and  redox
forms of oxygen.33The present study showed that TSV
is capable of enhancing NO production from perito-
neal macrophages (Fig. 3).
The  effects  of TSV  on  cytokines,  H2O2 and  NO
production were compared with those caused by LPS
stimulation. In the present study, the results showed
similar levels of IL-6 for both groups of macrophages
(Fig.  5).  In  contrast,  lower  levels  of  IFN-g were
observed for groups of macrophages stimulated with
TSV. With respect to in vitro stimulated macrophages,
it was observed that TSV induced an increase in H2O2
production when compared with those obtained in
macrophages  stimulated  with  LPS,  while  the  NO
production was higher in groups stimulated with LPS
(Fig.  6). Interestingly, on the contrary, these results
evidenced correlation of H2O2 and NO produced by
macrophages stimulated with TSV.
The effects of TSV combined with IFN-g were also
investigated. Peritoneal macrophages stimulated with
TSV fail to produce TNF either alone or in combina-
tion with IFN-g as a co-stimulus. The levels of NO and
H2O2 were significantly higher for groups of macro-
phages  stimulated  with TSV  combined  with  IFN-g.
These  results  suggest  that  one  compound  or  a
synergism  of  several  TSV  constituents  presented
immunomodulatory  activity  via  the  activation  of
macrophage  function  with  consequent  oxygen
metabolite  liberation. These results  agree  with  pre-
vious reports showing that priming of murine macro-
phages  with  IFN-g significantly  enhances  the  NO
production.34–36 However,  the  exact  mechanism in
which  these  molecules  interplay  is  not  completely
understood.
TSV inhibited the production of TNF and synergised
with  IFN-g to  stimulate  the  production  of  NO  by
macrophages. In conclusion, this study suggested that
TSV possesses immunomodulatory activities capable
of stimulating immune functions in vitro.
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